Vyant Bio Inc (VYNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,650 | -6,296 | -3,306 | -1,973 | -6,708 |
| Depreciation Amortization | 1,110 | 798 | 531 | 265 | 4,127 |
| Accounts receivable | -127 | -173 | -54 | -39 | 81 |
| Other Working Capital | 1,329 | 1,110 | 1,001 | 101 | -1,731 |
| Other Operating Activity | 526 | 215 | -209 | 111 | -4,429 |
| Operating Cash Flow | $-5,812 | $-4,346 | $-2,037 | $-1,535 | $-8,660 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -60 | -6 | 17 | N/A | -28 |
| Purchase Sale Intangibles | 17 | 17 | N/A | N/A | N/A |
| Other Investing Activity | 17 | 17 | 0 | 0 | 9,119 |
| Investing Cash Flow | $-43 | $11 | $17 | $N/A | $9,091 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,060 | 4,695 | 479 | 25 | N/A |
| Debt Repayment | -76 | -55 | -37 | -19 | -1,095 |
| Common Stock Issued | 98 | 85 | 23 | 23 | 5,412 |
| Other Financing Activity | 1,250 | 1,250 | 1,250 | 1,269 | -1,012 |
| Financing Cash Flow | $6,332 | $5,975 | $1,715 | $1,298 | $3,305 |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | -17 |
| Beginning Cash Position | 315 | 315 | 315 | 315 | 511 |
| End Cash Position | 792 | 1,955 | 10 | 78 | 4,230 |
| Net Cash Flow | $477 | $1,640 | $-305 | $-237 | $3,719 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,812 | -4,346 | -2,037 | -1,535 | -8,660 |
| Capital Expenditure | -60 | -6 | N/A | N/A | -28 |
| Free Cash Flow | -5,872 | -4,352 | -2,037 | -1,535 | -8,688 |